J 2022

mRNA Subtype of Cancer-Associated Fibroblasts Significantly Affects Key Characteristics of Head and Neck Cancer Cells

PELTANOVÁ, Barbora, Hana HOLCOVÁ POLANSKÁ, Martina RAUDENSKÁ, Jan BALVAN, Jiří NAVRÁTIL et. al.

Basic information

Original name

mRNA Subtype of Cancer-Associated Fibroblasts Significantly Affects Key Characteristics of Head and Neck Cancer Cells

Authors

PELTANOVÁ, Barbora (203 Czech Republic, belonging to the institution), Hana HOLCOVÁ POLANSKÁ (203 Czech Republic, belonging to the institution), Martina RAUDENSKÁ (203 Czech Republic, belonging to the institution), Jan BALVAN (203 Czech Republic, belonging to the institution), Jiří NAVRÁTIL (203 Czech Republic, belonging to the institution), Tomáš VIČAR (203 Czech Republic, belonging to the institution), Jaromír GUMULEC (203 Czech Republic, belonging to the institution), Barbora ČECHOVÁ (203 Czech Republic, belonging to the institution), Martin KRÄTER, Jochen GUCK, David KALFEŘT (203 Czech Republic), Marek GREGA (203 Czech Republic), Jan PLZÁK (203 Czech Republic), Jan BETKA (203 Czech Republic) and Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution)

Edition

Cancers, Basel, MDPI, 2022, 2072-6694

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.200

RIV identification code

RIV/00216224:14110/22:00125782

Organization unit

Faculty of Medicine

UT WoS

000794813300001

Keywords in English

cancer; HNSCC; cancer-associated fibroblasts; tumour microenvironment; cell stiffness

Tags

International impact, Reviewed
Změněno: 19/7/2022 10:45, Mgr. Tereza Miškechová

Abstract

V originále

Head and neck squamous cell carcinomas (HNSCC) belong among severe and highly complex malignant diseases showing a high level of heterogeneity and consequently also a variance in therapeutic response, regardless of clinical stage. Our study implies that the progression of HNSCC may be supported by cancer-associated fibroblasts (CAFs) in the tumour microenvironment (TME) and the heterogeneity of this disease may lie in the level of cooperation between CAFs and epithelial cancer cells, as communication between CAFs and epithelial cancer cells seems to be a key factor for the sustained growth of the tumour mass. In this study, we investigated how CAFs derived from tumours of different mRNA subtypes influence the proliferation of cancer cells and their metabolic and biomechanical reprogramming. We also investigated the clinicopathological significance of the expression of these metabolism-related genes in tissue samples of HNSCC patients to identify a possible gene signature typical for HNSCC progression. We found that the right kind of cooperation between cancer cells and CAFs is needed for tumour growth and progression, and only specific mRNA subtypes can support the growth of primary cancer cells or metastases. Specifically, during coculture, cancer cell colony supporting effect and effect of CAFs on cell stiffness of cancer cells are driven by the mRNA subtype of the tumour from which the CAFs are derived. The degree of colony-forming support is reflected in cancer cell glycolysis levels and lactate shuttle-related transporters.

Links

FW03010186, research and development project
Name: Nová biočipová a mikrofluidní diagnostika cirkulujících biomarkerů a farmakogenů u psychiatrických a onkologických onemocnění
Investor: Technology Agency of the Czech Republic, Subprograms 1 Technology leaders
GA18-03978S, research and development project
Name: Efekt buněčné tuhosti a mikroprostředí jako prediktor odpovědi na léčbu karcinomů hlavy a krku
Investor: Czech Science Foundation
LM2018129, research and development project
Name: Národní infrastruktura pro biologické a medicínské zobrazování Czech-BioImaging
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1133/2021, interní kód MU
Name: Od buňky k medicíně (Acronym: CELLVIEW)
Investor: Masaryk University
MUNI/A/1391/2021, interní kód MU
Name: Molekulární, buněčná, tkáňová a systémová patofyziologie vybraných komplexních nemocí (Acronym: KOMPLEX_PF)
Investor: Masaryk University
NV18-08-00229, research and development project
Name: Interakce buněk nádorového mikroprostředí jako nový nástroj predikce účinnosti terapie nádorů hlavy a krku
Investor: Ministry of Health of the CR